Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Wave Life Sciences (WVE) Accumulated Depreciation & Amortization (2016 - 2025)

Wave Life Sciences' Accumulated Depreciation & Amortization history spans 11 years, with the latest figure at $49.5 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 6.89% year-over-year to $49.5 million; the TTM value through Dec 2025 reached $49.5 million, up 6.89%, while the annual FY2025 figure was $49.5 million, 6.89% up from the prior year.
  • Accumulated Depreciation & Amortization reached $49.5 million in Q4 2025 per WVE's latest filing, up from $46.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $49.5 million in Q4 2025 to a low of $32.2 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $41.7 million, with a median of $42.7 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: rose 29.47% in 2021, then rose 6.89% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $32.2 million in 2021, then rose by 17.42% to $37.8 million in 2022, then rose by 12.85% to $42.7 million in 2023, then grew by 8.48% to $46.3 million in 2024, then increased by 6.89% to $49.5 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Accumulated Depreciation & Amortization are $49.5 million (Q4 2025), $46.3 million (Q4 2024), and $42.7 million (Q4 2023).